Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein O-glucosyltransferase 1 (POGLUT1) is an enzyme localized in the endoplasmic reticulum that catalyzes the transfer of glucose (and, to a lesser extent, xylose) to serine residues within specific consensus sequences of EGF-like repeats in multiple substrate proteins, especially Notch receptors[1][2][3][4][5][7]. Through this posttranslational modification, POGLUT1 is essential for proper Notch receptor folding and function, thereby enabling activation of the Notch signaling pathway, which is crucial for cellular differentiation, proliferation, and apoptosis throughout development and adult life[3][7]. Mutations or dysregulation of POGLUT1 are implicated in genetic disorders such as limb-girdle muscular dystrophy type 21 (LGMDR21) and Dowling-Degos disease, highlighting its pivotal role in both muscular and dermatologic tissue biology[3][6]. POGLUT1 belongs to the CAP10-like family of glycosyltransferases and shares structural and functional homology with its Drosophila homolog, Rumi[5][6].
Enzyme inhibition (theoretical, for any future inhibitors targeting Notch signaling regulation via POGLUT1 modulation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein O-glucosyltransferase 1 (POGLUT1).